Senseonics Holdings SENS
NASDAQ SENS
$8.72 -0.61 (-6.55%)
As of: Sep 9, 2026 · 3:59 PM EDT

Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026)

Senseonics Holdings' (SENS) quarterly Net Income towards Common Stockholders came in at -$36.7 million in Q2 2026, down 153.12% year-over-year from $69.1 million in Q2 2025, and down 13.65% quarter-over-quarter from -$32.3 million in Q1 2026.

Analysis

Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has reported Net Income towards Common Stockholders for 12 consecutive years, with -$36.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 153.12% year-over-year to -$36.7 million in Q2 2026; TTM through Jun 2026 was -$109.4 million, a 60.26% decrease from a year earlier, with the FY2025 full-year figure at -$69.1 million, up 12.3% from the prior year.
  • Net Income towards Common Stockholders was -$36.7 million for Q2 2026 at Senseonics Holdings, down from -$32.3 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$14.2 million in Q1 2025 and troughed at -$36.7 million in Q2 2026.
  • A 5-year average of -$21.3 million and a median of -$20.6 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders rose 28.87% in 2025 and plunged 153.12% in 2026, its largest moves.
  • Over 5 years, Net Income towards Common Stockholders stood at -$22.8 million in 2022, then increased by 24.41% to -$17.2 million in 2023, then increased by 9.97% to -$15.5 million in 2024, then tumbled by 34.1% to -$20.8 million in 2025, then slumped by 76.32% to -$36.7 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$36.7 million (Q2 2026), -$32.3 million (Q1 2026), and -$20.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 Senseonics Holdings 507.86 Mn 267.25 Mn 8.56 Mn -36.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.71 Mn
Mar 31, 2026 -32.30 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -19.54 Mn
Jun 30, 2025 -14.50 Mn
Mar 31, 2025 -14.24 Mn
Dec 31, 2024 -15.52 Mn
Sep 30, 2024 -23.97 Mn
Jun 30, 2024 -20.39 Mn
Mar 31, 2024 -18.90 Mn
Dec 31, 2023 -17.24 Mn
Sep 30, 2023 -19.99 Mn
Jun 30, 2023 -20.87 Mn
Mar 31, 2023 -23.25 Mn
Dec 31, 2022 -22.81 Mn
Sep 30, 2022 -21.83 Mn
Jun 30, 2022 -21.31 Mn
Mar 31, 2022 -19.56 Mn
Dec 31, 2021 -18.80 Mn
Sep 30, 2021 -19.79 Mn